Literature DB >> 26216297

A2A adenosine receptor deletion is protective in a mouse model of Tauopathy.

C Laurent, S Burnouf, B Ferry, V L Batalha, J E Coelho, Y Baqi, E Malik, E Marciniak, E Mariciniak, S Parrot, A Van der Jeugd, E Faivre, V Flaten, C Ledent, R D'Hooge, N Sergeant, M Hamdane, S Humez, C E Müller, L V Lopes, L Buée, D Blum.   

Abstract

Entities:  

Year:  2015        PMID： 26216297     DOI： 10.1038/mp.2015.115

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN： 1359-4184            Impact factor:   15.992


× No keyword cloud information.
  16 in total

Review 1.  Therapeutics of Neurotransmitters in Alzheimer's Disease.

Authors:  Ramesh Kandimalla; P Hemachandra Reddy
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

2.  Targeted neurogenesis pathway-based gene analysis identifies ADORA2A associated with hippocampal volume in mild cognitive impairment and Alzheimer's disease.

Authors:  Emrin Horgusluoglu-Moloch; Kwangsik Nho; Shannon L Risacher; Sungeun Kim; Tatiana Foroud; Leslie M Shaw; John Q Trojanowski; Paul S Aisen; Ronald C Petersen; Clifford R Jack; Simon Lovestone; Andrew Simmons; Michael W Weiner; Andrew J Saykin
Journal:  Neurobiol Aging       Date:  2017-08-18       Impact factor: 4.673

3.  Adenosine A2A receptor blockade prevents cisplatin-induced impairments in neurogenesis and cognitive function.

Authors:  Alfredo Oliveros; Ki Hyun Yoo; Mohammad Abdur Rashid; Ana Corujo-Ramirez; Benjamin Hur; Jaeyun Sung; Yuanhang Liu; John R Hawse; Doo-Sup Choi; Detlev Boison; Mi-Hyeon Jang
Journal:  Proc Natl Acad Sci U S A       Date:  2022-07-07       Impact factor: 12.779

4.  Istradefylline reduces memory deficits in aging mice with amyloid pathology.

Authors:  Anna G Orr; Iris Lo; Heike Schumacher; Kaitlyn Ho; Michael Gill; Weikun Guo; Daniel H Kim; Anthony Knox; Takashi Saito; Takaomi C Saido; Jeffrey Simms; Carlee Toddes; Xin Wang; Gui-Qiu Yu; Lennart Mucke
Journal:  Neurobiol Dis       Date:  2017-10-31       Impact factor: 5.996

Review 5.  Astrocytes and Adenosine A2A Receptors: Active Players in Alzheimer's Disease.

Authors:  Cátia R Lopes; Rodrigo A Cunha; Paula Agostinho
Journal:  Front Neurosci       Date:  2021-05-13       Impact factor: 4.677

6.  The Chemokine MIP-1α/CCL3 impairs mouse hippocampal synaptic transmission, plasticity and memory.

Authors:  Elodie Marciniak; Emilie Faivre; Patrick Dutar; Claire Alves Pires; Dominique Demeyer; Raphaëlle Caillierez; Charlotte Laloux; Luc Buée; David Blum; Sandrine Humez
Journal:  Sci Rep       Date:  2015-10-29       Impact factor: 4.379

7.  Astrocytic adenosine receptor A2A and Gs-coupled signaling regulate memory.

Authors:  Anna G Orr; Edward C Hsiao; Max M Wang; Kaitlyn Ho; Daniel H Kim; Xin Wang; Weikun Guo; Jing Kang; Gui-Qiu Yu; Anthony Adame; Nino Devidze; Dena B Dubal; Eliezer Masliah; Bruce R Conklin; Lennart Mucke
Journal:  Nat Neurosci       Date:  2015-01-26       Impact factor: 24.884

8.  Perivascular AQP4 dysregulation in the hippocampal CA1 area after traumatic brain injury is alleviated by adenosine A2A receptor inactivation.

Authors:  Zi-Ai Zhao; Ping Li; Shi-Yang Ye; Ya-Lei Ning; Hao Wang; Yan Peng; Nan Yang; Yan Zhao; Zhuo-Hang Zhang; Jiang-Fan Chen; Yuan-Guo Zhou
Journal:  Sci Rep       Date:  2017-05-22       Impact factor: 4.379

9.  The caffeine-binding adenosine A2A receptor induces age-like HPA-axis dysfunction by targeting glucocorticoid receptor function.

Authors:  Vânia L Batalha; Diana G Ferreira; Joana E Coelho; Jorge S Valadas; Rui Gomes; Mariana Temido-Ferreira; Tatiana Shmidt; Younis Baqi; Luc Buée; Christa E Müller; Malika Hamdane; Tiago F Outeiro; Michael Bader; Sebastiaan H Meijsing; Ghazaleh Sadri-Vakili; David Blum; Luísa V Lopes
Journal:  Sci Rep       Date:  2016-08-11       Impact factor: 4.379

Review 10.  In Vivo PET Imaging of Adenosine 2A Receptors in Neuroinflammatory and Neurodegenerative Disease.

Authors:  Anna Vuorimaa; Eero Rissanen; Laura Airas
Journal:  Contrast Media Mol Imaging       Date:  2017-11-20       Impact factor: 3.161
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.